Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
biotech
boston blog main
boston top stories
fda
national top stories
new york blog main
new york top stories
parkinson's disease
san diego blog main
san diego top stories
abbvie
acorda therapeutics
alder biopharmaceuticals
amgen
ampyra
apokyn
apomorphine
bial
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
dalfampridine
david rind
detroit blog main
detroit top stories
drug development
duopa
eli lilly
episodic migraine
eptinezumab
erenumab
food and drug administration
fremanezumab
galcanezumab
inbrija
indiana blog main
What
fda
gets
3
×
nod
3
×
disease
drug
new
parkinson’s
patients
acorda
add
amgen
approval
approved
called
candidates
carbidopa
class
combination
control
cope
daily
developed
episodes
experience
friday
head
help
late
levodopa
looms
meant
medication
medications
medicines
migraine
neurocrine
pain
pill
preventive
rival
Language
unset
Current search:
nod
×
gets
×
@xconomy.com
3 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
